Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML

Blood (2023) 142 (Supplement 1): 2854.

https://doi.org/10.1182/blood-2023-186277

Published: 2023

Journal Articles

Risk of Severe Sars-Cov-2 Infections in COVID-19 Vaccinated Individuals with Hematologic Malignancies (SAVE HEM): A Nationwide Cohort Study in the Netherlands

Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Abraham Goorhuis, Mette D. Hazenberg, Caroline E. Rutten, Sonja Zweegman, Jeanet Kemmeren, Nicolette F. de Keizer, Peter C. Huijgens, Avinash G. Dinmohamed, Susan van den Hof, Brechje de Gier, Mirjam Knol, Susan Hahné, Jarom Heijmans, Inger S. Nijhof

Blood (2023) 142 (Supplement 1): 546.

https://doi.org/10.1182/blood-2023-188561

Published: 2023

Journal Articles

Psychosocial challenges and health-related quality of life of adolescents and young adults with hematologic malignancies

Olga Husson, Peter C. Huijgens, Winette T. A. van der Graaf

Blood (2018) 132 (4): 385–392.

https://doi.org/10.1182/blood-2017-11-778555

Published: 2018

Journal Articles

Patterns of Primary Treatment, Trial Participation and Survival in Adult Acute Myeloid Leukemia: A Nationwide Population-Based Study Among Patients Diagnosed in the Netherlands from 1989 to 2012

Avinash G Dinmohamed, MSc, BASc, Otto Visser, MD PhD, Yvette van Norden, MSc, PhD, Nicole MA Blijlevens, MD PhD, Jan J. Cornelissen, MD PhD, Gerwin A Huls, MD PhD, Peter C Huijgens, MD PhD, Pieter Sonneveld, MDPhD, Arjan A van de Loosdrecht, MD PhD, Gert J Ossenkoppele, MD PhD, Bob Löwenberg, MD PhD, Mojca Jongen-Lavrencic, MD PhD

Blood (2014) 124 (21): 2631.

https://doi.org/10.1182/blood.V124.21.2631.2631

Published: 2014

Journal Articles

One Line Does Not Make a Picture: Real-World Cost-Effectiveness Of Multiple Myeloma Treatments Using a Full Disease Model

Hedwig M Blommestein, Silvia GR Verelst, Saskia de Groot, Peter C. Huijgens, MD, PhD, Pieter Sonneveld, MD, Ph.D, Carin A. Uyl-de Groot, PhD

Blood (2013) 122 (21): 2930.

https://doi.org/10.1182/blood.V122.21.2930.2930

Published: 2013

Journal Articles

Cost-Effectiveness of Rituximab As Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Population Based Study

Hedwig M Blommestein, Djamila E Issa, MD, Marjolein Pompen, PhD, Cédric Révil, Mels Hoogendoorn, MD, PhD, Peter Joosten, MD, Sonja Zweegman, MD, PhD, Peter C. Huijgens, MD, PhD, Carin A. Uyl-de Groot, PhD

Blood (2012) 120 (21): 4277.

https://doi.org/10.1182/blood.V120.21.4277.4277

Published: 2012

Journal Articles

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Edo Vellenga, Wim van Putten, Gert J. Ossenkoppele, Leo F. Verdonck, Matthias Theobald, Jan J. Cornelissen, Peter C. Huijgens, Johan Maertens, Alois Gratwohl, Ron Schaafsma, Urs Schanz, Carlos Graux, Harry C. Schouten, Augustin Ferrant, Mario Bargetzi, Martin F. Fey, Bob Löwenberg, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), and Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Blood (2011) 118 (23): 6037–6042.

https://doi.org/10.1182/blood-2011-07-370247

Published: 2011

Includes: Supplemental data

Journal Articles

Does 18F-Fluorodeoxyglucose Outperform 18F-Fluorothymidine When Using Positron Emission Tomography in Predicting Transformation of Indolent Non-Hodgkin's Lymphoma,

Marielle Wondergem, MD, Josee Zijlstra, Nikie Hoetjes, Martine ED Chamuleau, MD, Sonja Zweegman, MD PhD, Peter C. Huijgens, MD, PhD, Ronald Boellaard, Otto s Hoekstra

Blood (2011) 118 (21): 3658.

https://doi.org/10.1182/blood.V118.21.3658.3658

Published: 2011

Journal Articles

Cost of Autologous and Allogeneic Stem Cell Transplantations for Hematological Disease: A Dutch Multicenter Daily Practice Study

Hedwig M Blommestein, Silvia GR Verelst, Jan J Cornelissen, MD, PhD, Peter C Huijgens, MD, PhD, Nicole MA Blijlevens, MD, PhD, Carin A Uyl-de Groot, PhD

Blood (2011) 118 (21): 2079.

https://doi.org/10.1182/blood.V118.21.2079.2079

Published: 2011

Journal Articles

Trends in Incidence and Survival of Multiple Myeloma in the Netherlands in the Last Two Decades. Results From a National Population Based Study

Silvia GR Verelst, Hedwig M Blommestein, Henrike E Karim-Kos, Peter C Huijgens, Pieter Sonneveld, MD, PhD

Blood (2011) 118 (21): 5071.

https://doi.org/10.1182/blood.V118.21.5071.5071

Published: 2011

Journal Articles

90 yttrium Ibritumomab Tiuxetan-BEAM Followed by Autologous Stem Cell Transplantation Significantly Improves Overall Survival After Rituximab Containing Induction Therapy in Patients with High-Risk Aggressive B Cell Non-Hodgkin's Lymphoma

Marielle Wondergem, MD, Madelon de Rooij, MD, Josee Zijlstra, Otto J Visser, MD, Gert Ossenkoppele, MD, PhD, Peter C. Huijgens, MD, PhD

Blood (2011) 118 (21): 3078.

https://doi.org/10.1182/blood.V118.21.3078.3078

Published: 2011

Journal Articles

High Prognostic Impact of Flowcytometric Minimal Residual Disease Detection In Acute Myeloid Leukemia: Prospective Data From the HOVON/SAKK 42a Study

Monique Terwijn, Angèle Kelder, Wim L.J. van Putten, Alexander N. Snel, Vincent H.J. van der elden, PhD, Rik A. Brooimans, PhD, Nancy Boeckx, MD, PhD, Frank W.M.B. Preijers, PhD, Bob Löwenberg, MD, PhD, Angelika M. Dräger, PhD, Peter C. Huijgens, MD, PhD, Peter J.M Valk, PhD, Johan Maertens, MD, Thomas Pabst, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD

Blood (2010) 116 (21): 760.

https://doi.org/10.1182/blood.V116.21.760.760

Published: 2010

Journal Articles

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20 + NHL: a prospective randomized HOVON trial

Edo Vellenga, Wim L. J. van Putten, Mars B. van 't Veer, Josée M. Zijlstra, Willem E. Fibbe, Marinus H. J. van Oers, Leo F. Verdonck, Pierre W. Wijermans, Gustaaf W. van Imhoff, Pieternella J. Lugtenburg, Peter C. Huijgens

Blood (2008) 111 (2): 537–543.

https://doi.org/10.1182/blood-2007-08-108415

Published: 2008

Includes: Supplemental data

Journal Articles

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L. J. van Putten, Leo F. Verdonck, Matthias Theobald, Emanuel Jacky, Simon M. G. Daenen, Marinus van Marwijk Kooy, Pierre Wijermans, Harry Schouten, Peter C. Huijgens, Hans van der Lelie, Martin Fey, Augustin Ferrant, Johan Maertens, Alois Gratwohl, Bob Lowenberg

Blood (2007) 109 (9): 3658–3666.

https://doi.org/10.1182/blood-2006-06-025627

Published: 2007

Includes: Supplemental data

Journal Articles

Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

Abdulbaqi Al-toma, Otto J. Visser, Hyacintha M. van Roessel, B. Mary E. von Blomberg, Wieke H. M. Verbeek, Petra E. T. Scholten, Gert J. Ossenkoppele, Peter C. Huijgens, Chris J. J. Mulder

Blood (2006) 109 (5): 2243–2249.

https://doi.org/10.1182/blood-2006-08-042820

Published: 2006

Journal Articles

HOVON 50/GMMG-HD3-Trial: Phase III Study on the Effect of Thalidomide Combined with High Dose Melphalan in Myeloma Patients up to 65 Years.

Blood (2005) 106 (11): 424.

https://doi.org/10.1182/blood.V106.11.424.424

Published: 2005

Journal Articles

Systematic Review of 18 F-Fluorodeoxyglucose Positron Emission Tomography for Post-Treatment Evaluation of Malignant Lymphoma.

Josée M. Zijlstra, MD, Otto S. Hoekstra, MD, PhD, Gerda Lindauer-van der Werf, MD, Lotty Hooft, MSc, PhD, Ingrid I. Riphagen, MSc, Peter C. Huijgens, MD, PhD

Blood (2005) 106 (11): 3340.

https://doi.org/10.1182/blood.V106.11.3340.3340

Published: 2005

Journal Articles

Biochemical Characterization and Gene Expression Profiling of Cytarabine Treated Stromal Fibroblasts Reveal Regulatory Mechanisms Affecting Hyaluronan and Heparan Sulfate Proteoglycans.

Sonja Zweegman, MD, Floortje L. Kessler, Ron Kerkhoven, PhD, Mike Heimerikx, Peter C. Huijgens, MD PhD, Angelika M. Drager, PhD, Jacob van den Born, PhD

Blood (2004) 104 (11): 1304.

https://doi.org/10.1182/blood.V104.11.1304.1304

Published: 2004

Journal Articles

Immunophenotypical Sequential MRD Assessment in AML for Prediction of Relapse and Definition of Putative Future Intervention Time Points.

Nicole Feller, Peter C. Huijgens, MD, PhD, Angele Kelder, Guus Westra, Gert Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD

Blood (2004) 104 (11): 3012.

https://doi.org/10.1182/blood.V104.11.3012.3012

Published: 2004

Journal Articles

Conditioning Regimens in Stem Cell Transplantations Facilitate Homing by Increasing Bone Marrow SDF-1 through Induction of SDF-1 Gene Transcription.

Sonja Zweegman, MD, Jeroen J.W.M. Janssen, MD, Floortje L. Kessler, Adriana M.C. Mus, Jacob van den Born, PhD, Peter C. Huijgens, MD, PhD, Angelika M. Drager, PhD

Blood (2004) 104 (11): 4958.

https://doi.org/10.1182/blood.V104.11.4958.4958

Published: 2004

NARROW

Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AML

Risk of Severe Sars-Cov-2 Infections in COVID-19 Vaccinated Individuals with Hematologic Malignancies (SAVE HEM): A Nationwide Cohort Study in the Netherlands

Psychosocial challenges and health-related quality of life of adolescents and young adults with hematologic malignancies

Patterns of Primary Treatment, Trial Participation and Survival in Adult Acute Myeloid Leukemia: A Nationwide Population-Based Study Among Patients Diagnosed in the Netherlands from 1989 to 2012

One Line Does Not Make a Picture: Real-World Cost-Effectiveness Of Multiple Myeloma Treatments Using a Full Disease Model

Cost-Effectiveness of Rituximab As Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Population Based Study

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Does 18F-Fluorodeoxyglucose Outperform 18F-Fluorothymidine When Using Positron Emission Tomography in Predicting Transformation of Indolent Non-Hodgkin's Lymphoma,

Cost of Autologous and Allogeneic Stem Cell Transplantations for Hematological Disease: A Dutch Multicenter Daily Practice Study

Trends in Incidence and Survival of Multiple Myeloma in the Netherlands in the Last Two Decades. Results From a National Population Based Study

90 yttrium Ibritumomab Tiuxetan-BEAM Followed by Autologous Stem Cell Transplantation Significantly Improves Overall Survival After Rituximab Containing Induction Therapy in Patients with High-Risk Aggressive B Cell Non-Hodgkin's Lymphoma

High Prognostic Impact of Flowcytometric Minimal Residual Disease Detection In Acute Myeloid Leukemia: Prospective Data From the HOVON/SAKK 42a Study

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20 + NHL: a prospective randomized HOVON trial

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

HOVON 50/GMMG-HD3-Trial: Phase III Study on the Effect of Thalidomide Combined with High Dose Melphalan in Myeloma Patients up to 65 Years.

Systematic Review of 18 F-Fluorodeoxyglucose Positron Emission Tomography for Post-Treatment Evaluation of Malignant Lymphoma.

Biochemical Characterization and Gene Expression Profiling of Cytarabine Treated Stromal Fibroblasts Reveal Regulatory Mechanisms Affecting Hyaluronan and Heparan Sulfate Proteoglycans.

Immunophenotypical Sequential MRD Assessment in AML for Prediction of Relapse and Definition of Putative Future Intervention Time Points.

Conditioning Regimens in Stem Cell Transplantations Facilitate Homing by Increasing Bone Marrow SDF-1 through Induction of SDF-1 Gene Transcription.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only